@article{d370bf2ef00e46ada3a342db916ae6a6,
title = "Evaluation of a novel electrochemical detection method for Chlamydia trachomatis: Application for point-of-care diagnostics",
abstract = "Atlas Genetics has developed a point-of-care device for Chlamydia trachomatis utilizing a novel electrochemical detection principle. The assay has a time-to-result of less than 25 min. An independent preclinical validation study using 306 pretyped clinical samples determined a clinical sensitivity of 98.1% and specificity of 98.0%.",
keywords = "Chlamydia, electrochemistry, infectious disease, point-of-care",
author = "Pearce, {David M.} and Shenton, {Daniel P.} and Jeffrey Holden and Gaydos, {Charlotte A.}",
note = "Funding Information: Manuscript received July 12, 2010; revised October 15, 2010; accepted November 21, 2010. Date of publication November 29, 2010; date of current version February 18, 2011. This work was supported by the U.S. National Institutes of Health, Bethesda, MD, under Grant U54 EB007958. Asterisk indicates corresponding author. *D. M. Pearce is with Atlas Genetics Ltd., Trowbridge, Wiltshire, BA14 0XG, U.K. (e-mail: david.pearce@atlasgenetics.com).",
year = "2011",
month = mar,
doi = "10.1109/TBME.2010.2095851",
language = "English (US)",
volume = "58",
pages = "755--758",
journal = "IEEE Transactions on Biomedical Engineering",
issn = "0018-9294",
publisher = "IEEE Computer Society",
number = "3 PART 2",
}